Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar 6:8:31.
doi: 10.1186/1471-2334-8-31.

Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility

Affiliations

Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility

Steven F J Callens et al. BMC Infect Dis. .

Abstract

Background: The performance of the WHO recommendations for pediatric antiretroviral treatment (ART) in resource poor settings is insufficiently documented in routine care.

Methods: We compared clinical and immunological criteria in 366 children aged 0 to 12 years in Kinshasa and evaluated a simple computation to estimate CD4 percent, based on CD4 count, total white blood cell count and percentage lymphocytes. Kappa (kappa) statistic was used to evaluate eligibility criteria and linear regression to determine trends of CD4 percent, count and total lymphocyte count (TLC).

Results: Agreement between clinical and immunological eligibility criteria was poor (kappa = 0.26). One third of children clinically eligible for ART were ineligible using immunological criteria; one third of children immunologically eligible were ineligible using clinical criteria. Among children presenting in WHO stage I or II, 54 (32%) were eligible according to immunological criteria. Agreement with CD4 percent was poor for TLC (kappa = 0.04), fair for total CD4 count (kappa = 0.39) and substantial for CD4 percent computational estimate (kappa = 0.71). Among 5 to 12 years old children, total CD4 count was higher in younger age groups (-32 cells/mm3 per year older), CD4 percent was similar across age groups.

Conclusion: Age-specific thresholds for CD4 percent optimally determine pediatric ART eligibility. The use of CD4 percent computational estimate may increase ART access in settings with limited access to CD4 percent assays.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CD4 percent obtained by flow cytometry and computational estimate by age group: (A) 0 to 11 months, (B) 12 to 35 months, (C) 36 to 59 months, (D) 60 to 95 months (E) more than 95 months. Grey areas indicate children misclassified using CD4 percent computational estimate compared to CD4 percent obtained by flow cytometry.
Figure 2
Figure 2
Baseline total CD4 count and total lymphocyte count (TLC) decrease with increasing age (p < 0.01). CD4 percent obtained by flow cytometryandcomputational estimate are stable with increasing age (p > 0.05). Linear prediction (and 95%CI) of CD4 percent obtained by flow cytometry (solid line), CD4 percent computational estimate (dashed line), total CD4 count (long dash line) and TLC (long dash – dotted line) in children aged 5 to 12 years.

References

    1. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf - PubMed
    1. Walker AS, Mulenga V, Sinyinza F, Lishimpi K, Nunn A, Chintu C, Gibb DM. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr. 2006;42:637–645. doi: 10.1097/01.qai.0000226334.34717.dc. - DOI - PubMed
    1. HIV Paediatric Prognostic Markers Collaborative Study Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data. Lancet. 2005;366:1868–1874. doi: 10.1016/S0140-6736(05)67757-4. - DOI - PubMed
    1. Bachou H, Tylleskar T, Downing R, Tumwine JK. Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4+ cell count. Nutr J. 2006;5:27. doi: 10.1186/1475-2891-5-27. - DOI - PMC - PubMed
    1. Lugada ES, Mermin J, Kaharuza F, Ulvestad E, Were W, Langeland N, Asjo B, Malamba S, Downing R. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol. 2004;11:29–34. doi: 10.1128/CDLI.11.1.29-34.2004. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances